World Health Organization (WHO). Global action plan for the prevention and control of noncommunicable diseases 2013–2020. In: Follow-up to the political declaration of the high-level meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases 2013. Geneva: World Health Organization, 2013.
2.
GutholdRStevensGARileyLM, et al.Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health2018; 6: e1077–e1086.
3.
YoungDRHivertMFAlhassanS, et al.Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council. Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association. Circulation2016; 134: e262–e279.
4.
FletcherGFLandolfoCNiebauerJ, et al.Promoting Physical Activity and Exercise: JACC Health Promotion Series. JACC2018; 72: 1622–1639.
5.
LindLElmståhlSBergmanE, et al.EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases. Eur J Epidemiol2013; 28: 189–197.
6.
HarrisHHåkanssonNOlofssonC, et al.The Swedish mammography cohort and the cohort of Swedish men: study design and characteristics of two population-based longitudinal cohorts. OA Epidemiology2013; 1: 16–16.
7.
StattinKLindLElmståhlS, et al.Physical activity is associated with a large number of cardiovascular-specific proteins: Cross-sectional analyses in two independent cohorts. Eur J Prev Cardiol. 2019; 26: 1865–1873.
8.
CaiJYuanSXYangF, et al.Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma. Oncotarget2016; 7: 70045–70057.
9.
ArendWPGuthridgeCJ. Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis2000; 59: i60–i64.
10.
FuruhashiMSaitohSShimamotoK, et al.Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol2015; 8: 23–33.
11.
Ubaida-MohienCGonzalez-FreireMLyashkovA, et al.Physical activity associated proteomics of skeletal muscle: being physically active in daily life may protect skeletal muscle from aging. Front Physiol2019; 10: 312–312.
